29, the Ministry of Industry and Information Technology organized a press conference on the "Security Situation of Key Medical Supplies for Epidemic Prevention and Control". At the meeting, Wang Jiangping, a member of the Party Leadership Group and Vice Minister of the Ministry of Industry and Information Technology, introduced that more than 750 key enterprises in key provinces such as Shandong, Hubei, Liaoning, Henan, Shanxi, and Hebei have been organized to do everything possible to expand the production capacity of enterprises and continue to improve the production and supply capacity of key medical supplies such as vaccines, therapeutic drugs, testing reagents, and protective equipment. According to the peak time of the epidemic in various places, precise allocation will be carried out according to priorities, and all efforts will be made to ensure the epidemic prevention and control needs of key areas and key groups.
data map. China Economic Network Photo by Hu Chenxi
Ibuprofen and Acetaminophen The daily production capacity of two key antipyretic and analgesic drugs has reached 202 million tablets, and the daily output has reached 190 million tablets. Compared with the beginning of December, the current daily production and supply have increased by more than 4 times. Since December 1, a total of 2.488 billion pieces have been produced, and 2.412 billion pieces have been supplied to the market. The main production provinces include Shandong, Hubei, Shanxi, etc.
The maximum daily output of four categories of children's antipyretics, including ibuprofen and acetaminophen suspension, dry suspension, granules, and oral liquid, has reached 1.12 million bottles. The main production provinces include Shanghai, Jiangsu, Guangdong, etc.; in addition, the daily output of pediatric acetaminophen, xantamine, and pediatric acetaminophen has reached 15.7 million bags.
data map. Photo by Peng Jinmei of China Economic Network
In terms of antigen detection reagents, the company's daily production capacity has expanded from 60 million doses in early December to 110 million doses, an increase of 83%. Since December 1, a total of 1.49 billion servings have been produced, supplying a market of 1.67 billion servings.
In terms of new coronavirus vaccines , my country has currently 13 new crown vaccines approved for conditional marketing or approved for emergency use. It has built the world's largest new coronavirus vaccine production line, with an annual production capacity of more than 7 billion doses and an output of more than 5.5 billion doses, which can meet the needs of "all-in-one". Among them, the four vaccines recently approved for emergency use have increased production capacity by more than 2 billion doses.
data map. China Economic Network Photo by Luo Yan
In response to the recent rise in demand for N95 masks, the Ministry of Industry and Information Technology has expanded the scope of dispatching companies to more than 500 companies, with a daily production capacity of more than 190 million.
The production and supply of finger-clip pulse oximeters has been increased, and the daily output has increased from 115,000 units in early December to more than 250,000 units.
In light of the peak situation of the epidemic, the Ministry of Industry and Information Technology has coordinated and strengthened inter-provincial allocation to ensure the production and supply of key medical supplies. As of December 28, a total of 174 million ibuprofen tablets, 60 million acetaminophen tablets, and antigen detection reagents have been allocated to key areas across provinces for more than 550 million people.
Explore the establishment of a "Drug Purchase Guarantee Platform for People Infected with the New Coronavirus"
Currently, there is panic buying and hoarding of medicines in some areas, and patients' needs for some scarce drugs cannot be met. The Ministry of Industry and Information Technology, in conjunction with the Ministry of Commerce, has organized large e-commerce platforms such as Alibaba Pharmacy, JD Health, and Meituan to explore the establishment of a "Drug Purchase Guarantee Platform for People Infected with the New Coronavirus" based on pilot projects in Tianjin and Shijiazhuang. Currently, the platform has been launched in 11 provinces and cities including Beijing, Zhejiang, and Hebei, delivering 6.6 million doses of various medicines, serving nearly 2 million patients, and serving 80% of the population in rural and remote areas.
Comprehensive Economic Daily reporter Huang Xin, Xinhua News Agency
Source: China Economic Network
